Health Akero’s Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial Posted on March 5, 2024 by miyuru (Reuters) -Akero Therapeutics’ speculative drug for a kind of fatty liver illness considerably minimized scarring after almost 2 years in a mid-stage research study, it stated on Monday, as the….